Toll Free: 1-888-928-9744
Published: Dec, 2015 | Pages:
26 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
VivaCell Biotechnology Espana S.L. - Product Pipeline Review - 2015 Summary Global Markets Direct's, 'VivaCell Biotechnology Espana S.L. - Product Pipeline Review - 2015', provides an overview of the VivaCell Biotechnology Espana S.L.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of VivaCell Biotechnology Espana S.L.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of VivaCell Biotechnology Espana S.L. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of VivaCell Biotechnology Espana S.L.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the VivaCell Biotechnology Espana S.L.'s pipeline products Reasons to buy - Evaluate VivaCell Biotechnology Espana S.L.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of VivaCell Biotechnology Espana S.L. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the VivaCell Biotechnology Espana S.L.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of VivaCell Biotechnology Espana S.L. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of VivaCell Biotechnology Espana S.L. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope - Explore the dormant and discontinued projects of VivaCell Biotechnology Espana S.L. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 VivaCell Biotechnology Espana S.L. Snapshot 5 VivaCell Biotechnology Espana S.L. Overview 5 Key Information 5 Key Facts 5 VivaCell Biotechnology Espana S.L. - Research and Development Overview 6 Key Therapeutic Areas 6 VivaCell Biotechnology Espana S.L. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Partnered Products 10 Partnered Products/Combination Treatment Modalities 11 VivaCell Biotechnology Espana S.L. - Pipeline Products Glance 12 VivaCell Biotechnology Espana S.L. - Early Stage Pipeline Products 12 Preclinical Products/Combination Treatment Modalities 12 Discovery Products/Combination Treatment Modalities 13 VivaCell Biotechnology Espana S.L. - Drug Profiles 14 CDE-001 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 VCE-003 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 VCE-0032 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 VCE-0048 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 VivaCell Biotechnology Espana S.L. - Pipeline Analysis 18 VivaCell Biotechnology Espana S.L. - Pipeline Products by Target 18 VivaCell Biotechnology Espana S.L. - Pipeline Products by Route of Administration 19 VivaCell Biotechnology Espana S.L. - Pipeline Products by Molecule Type 20 VivaCell Biotechnology Espana S.L. - Pipeline Products by Mechanism of Action 21 VivaCell Biotechnology Espana S.L. - Recent Pipeline Updates 22 VivaCell Biotechnology Espana S.L. - Dormant Projects 23 VivaCell Biotechnology Espana S.L. - Locations And Subsidiaries 24 Head Office 24 Appendix 25 Methodology 25 Coverage 25 Secondary Research 25 Primary Research 25 Expert Panel Validation 25 Contact Us 25 Disclaimer 26
List of Tables
VivaCell Biotechnology Espana S.L., Key Information 5 VivaCell Biotechnology Espana S.L., Key Facts 5 VivaCell Biotechnology Espana S.L. - Pipeline by Indication, 2015 7 VivaCell Biotechnology Espana S.L. - Pipeline by Stage of Development, 2015 8 VivaCell Biotechnology Espana S.L. - Monotherapy Products in Pipeline, 2015 9 VivaCell Biotechnology Espana S.L. - Partnered Products in Pipeline, 2015 10 VivaCell Biotechnology Espana S.L. - Partnered Products/ Combination Treatment Modalities, 2015 11 VivaCell Biotechnology Espana S.L. - Preclinical, 2015 12 VivaCell Biotechnology Espana S.L. - Discovery, 2015 13 VivaCell Biotechnology Espana S.L. - Pipeline by Target, 2015 18 VivaCell Biotechnology Espana S.L. - Pipeline by Route of Administration, 2015 19 VivaCell Biotechnology Espana S.L. - Pipeline by Molecule Type, 2015 20 VivaCell Biotechnology Espana S.L. - Pipeline Products by Mechanism of Action, 2015 21 VivaCell Biotechnology Espana S.L. - Recent Pipeline Updates, 2015 22 VivaCell Biotechnology Espana S.L. - Dormant Developmental Projects,2015 23
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.